← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 24, 2017Last known activity
Nov 24, 2017
Timeline
2000s
- Aug 18, 2009
Immungenetics AG— Founded
Drugs by trial phase (1 distinct, 1 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (1)
- NCT03417986Lead sponsorPhase 2Nov 24, 2017
Details
- Founded
- Rostock, DE Aug 18, 2009
- Last known activity
- Nov 24, 2017